Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.
Reijers ILM, Menzies AM, van Akkooi ACJ, Versluis JM, van den Heuvel NMJ, Saw RPM, Pennington TE, Kapiteijn E, van der Veldt AAM, Suijkerbuijk KPM, Hospers GAP, Rozeman EA, Klop WMC, van Houdt WJ, Sikorska K, van der Hage JA, Grünhagen DJ, Wouters MW, Witkamp AJ, Zuur CL, Lijnsvelt JM, Torres Acosta A, Grijpink-Ongering LG, Gonzalez M, Jóźwiak K, Bierman C, Shannon KF, Ch'ng S, Colebatch AJ, Spillane AJ, Haanen JBAG, Rawson RV, van de Wiel BA, van de Poll-Franse LV, Scolyer RA, Boekhout AH, Long GV, Blank CU. Reijers ILM, et al. Among authors: jozwiak k. Nat Med. 2022 Jun;28(6):1178-1188. doi: 10.1038/s41591-022-01851-x. Epub 2022 Jun 5. Nat Med. 2022. PMID: 35661157 Clinical Trial.
Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
Theunissen EA, Zuur CL, Józwiak K, Lopez-Yurda M, Hauptmann M, Rasch CR, van der Baan S, de Boer JP, Dreschler WA, Balm AJ. Theunissen EA, et al. Among authors: jozwiak k. JAMA Otolaryngol Head Neck Surg. 2015 Sep;141(9):810-5. doi: 10.1001/jamaoto.2015.1515. JAMA Otolaryngol Head Neck Surg. 2015. PMID: 26291150
Clinical Prognostic Markers in Stage IIIB Melanoma.
Madu MF, Wouters MW, Klop WM, van der Hiel B, van de Wiel BA, Jóźwiak K, van der Hage JA, van Akkooi AC. Madu MF, et al. Among authors: jozwiak k. Ann Surg Oncol. 2016 Dec;23(13):4195-4202. doi: 10.1245/s10434-016-5396-8. Epub 2016 Jul 5. Ann Surg Oncol. 2016. PMID: 27380642
Clinical prognostic markers in stage IIIC melanoma.
Madu MF, Schopman JHH, Berger DMS, Klop WMC, Jóźwiak K, Wouters MWJM, van der Hage JA, van Akkooi ACJ. Madu MF, et al. Among authors: jozwiak k. J Surg Oncol. 2017 Aug;116(2):244-251. doi: 10.1002/jso.24635. Epub 2017 Apr 15. J Surg Oncol. 2017. PMID: 28411392
Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria.
Madu MF, Franke V, Bruin MM, Berger DMS, Bierman C, Jóźwiak K, Klop WMC, Wouters MWJM, van Akkooi ACJ, Van de Wiel BA. Madu MF, et al. Among authors: jozwiak k. Eur J Cancer. 2017 Dec;87:212-215. doi: 10.1016/j.ejca.2017.09.002. Epub 2017 Oct 3. Eur J Cancer. 2017. PMID: 28986137 No abstract available.
196 results